MARKET

NTRBW

NTRBW

Nutriband
NASDAQ
1.550
-0.060
-3.73%
Closed 09:54 05/13 EDT
OPEN
1.570
PREV CLOSE
1.610
HIGH
1.570
LOW
1.550
VOLUME
1.14K
TURNOVER
0
52 WEEK HIGH
5.25
52 WEEK LOW
0.5110
MARKET CAP
--
P/E (TTM)
-1.5685
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NTRBW last week (0505-0509)?
Weekly Report · 2d ago
Weekly Report: what happened at NTRBW last week (0428-0502)?
Weekly Report · 05/05 10:16
Nutriband Inc reports results for the quarter ended January 31 - Earnings Summary
Reuters · 04/29 17:23
Weekly Report: what happened at NTRBW last week (0421-0425)?
Weekly Report · 04/28 10:21
Weekly Report: what happened at NTRBW last week (0414-0418)?
Weekly Report · 04/21 10:21
Weekly Report: what happened at NTRBW last week (0407-0411)?
Weekly Report · 04/14 10:15
Nutriband Secures Macao Patent for AVERSA, Expanding Global Protection for Abuse-Deterrent Opioid Patch, Eyes Up to $200M in Peak US Sales
Benzinga · 04/11 11:03
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
Barchart · 04/11 06:00
More
About NTRBW
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Webull offers Nutriband Inc stock information, including NASDAQ: NTRBW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRBW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTRBW stock methods without spending real money on the virtual paper trading platform.